Zeuzem, S <br/><br/>
Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin.  [electronic resource] 

 -  Journal of viral hepatitis  Nov 2012 
 - 766-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2893.2012.01624.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Hepacivirus--genetics<br/>Hepatitis C--drug therapy<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--therapeutic use<br/>RNA, Viral--blood<br/>ROC Curve<br/>Recombinant Proteins--therapeutic use<br/>Retrospective Studies<br/>Ribavirin--therapeutic use<br/>Treatment Outcome<br/>Viral Load